Application of Next-Generation Sequencing in Precision Medicine for Cancer Diagnosis and Treatment

Thesis Abstract

Abstract
This thesis explores the application of Next-Generation Sequencing (NGS) in precision medicine for cancer diagnosis and treatment. Cancer continues to be a leading cause of mortality worldwide, necessitating innovative approaches for personalized diagnosis and targeted therapy. NGS technology has revolutionized genomic analysis, enabling comprehensive profiling of cancer genomes and facilitating the identification of genetic alterations that drive tumorigenesis. This research investigates the integration of NGS into clinical practice to enhance precision medicine strategies in cancer management. The introduction provides an overview of the research aims to capitalize on the potential of NGS in revolutionizing cancer care. The background of the study delves into the evolution of NGS technology, highlighting its capabilities in high-throughput sequencing and data analysis. The problem statement underscores the limitations of conventional cancer diagnostic methods in capturing the complexity of tumor biology and guiding treatment decisions based on individual genetic profiles. The objectives of the study focus on elucidating the role of NGS in personalized cancer therapy and evaluating its impact on patient outcomes. The literature review delves into ten key areas, including the principles of precision medicine, the molecular basis of cancer, NGS applications in oncology, bioinformatics tools for data interpretation, and clinical implementation challenges. The research methodology outlines the study design, sample collection procedures, NGS workflow, data analysis strategies, and statistical methods employed to assess the clinical utility of NGS in cancer diagnosis and treatment. The discussion of findings presents a detailed analysis of the results obtained from NGS profiling of cancer patients, emphasizing the identification of actionable genetic alterations, treatment response prediction, and therapy optimization. The implications of NGS-based precision medicine in improving patient outcomes, minimizing adverse effects, and guiding targeted therapy selection are critically evaluated. In conclusion, this thesis underscores the transformative potential of NGS in advancing precision medicine for cancer patients. By harnessing the power of genomic sequencing technologies, clinicians can tailor treatment regimens to individual genetic profiles, leading to more effective and personalized cancer care. The summary encapsulates the key findings, challenges, and future directions in the integration of NGS into clinical oncology practice to optimize cancer diagnosis and therapy.